PRIMARY STUDY

Effects of Delta9-tetrahydrocannabivarin on [35S]GTPgammaS binding in mouse brain cerebellum and piriform cortex membranes

Key Findings:  Delta-9-THCV are CB1 receptor antagonists in the cerebellum and piriform cortical.

Type of Study:  Laboratory Study

Study Result:  Inconclusive

Study Location(s):  United Kingdom

Year of Pub:  2019


Cannabinoids Studied:  Tetrahydrocannabivarin (THCV)

Phytocannabinoid Source:  Unspecified

Receptors Studied:  CB1

Route of Administration:  In vitro



Link to study